/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today.
/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company"), a biopharmaceutical company developing innovative cell therapy platforms.